On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have now been extended by one month.
Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
Coronavirus and the fight led by the FAMHP: rigorous work to ensure each patient receives the treatment they need
Since the start of the coronavirus pandemic, the FAMHP teams have been working relentlessly to support hospitals and pharmacies facing difficulties in securing supplies of medicinal products. Here is an overview of the measures put in place by the FAMHP to guarantee stocks of medicinal products in Belgium.
Due to a worldwide increase in demand for the Gardasil 9 vaccine, used to prevent Human Papillomavirus (HPV), stocks of this vaccine are currently limited in Belgium. This limited availability has been extended and should continue until September 2020. The Federal Agency for Medicines and Health Products (FAMHP) has updated the recommendations for prescribers.
Coronavirus: extension and relaxing of measures taken by the FAMHP to avoid medicinal product shortages
On 1 April 2020, the FAMHP took steps to avoid a shortage of medicinal products. Some of these measures are to be further extended by one month, while others have been lifted.
The FAMHP reminds hospitals of the recommendations for replacing closed suction systems and offers temporary practical advice to help healthcare professionals waiting on a new stock of suction systems.
On 1 April 2020, the FAMHP took steps to avoid a shortage of medicinal products. These actions will now be extended by one month until 1 June 2020.
Stocks of essential medicinal products to treat COVID-19 patients in hospital are being closely monitored. There are currently solutions and alternatives for all medicinal products necessary for the treatment of COVID-19 patients in Belgium.
Coronavirus: joint statement from the FAMHP and the ABSYM/BVAS (Belgian association of unions for medical practitioners) responding to the concerns of healthcare professionals in the field
The FAMHP and the Belgian association of unions for medical practitioners (ABSYM/BVAS) met this Wednesday, 16 April 2020, in a constructive and sincere atmosphere. The FAMHP explained that its teams are working hard to resolve the difficulties that certain hospitals have faced in obtaining supplies of medicinal products since the start of the COVID-19 pandemic. The emergency aid service was able to resolve temporary shortages encountered by hospitals.
Sales of paracetamol in pharmacies have returned to normal. As a result, some of the measures taken by the FAMHP in mid-March have been softened. Pharmaceutical companies and wholesaler-distributors no longer need to apply quotas, except in the case of intravenous infusion. Delivery is, however, still limited to one box per patient.
Coronavirus: measures taken by the FAMHP and relevant partners to continue to guarantee oxygen supplies
Due to the COVID-19 pandemic, there is an increased need for oxygen in Belgium for patients with respiratory problems. The FAMHP and its relevant partners, assembled as part of the Task Force in charge of the management of medical devices and medicinal products, are taking measures to guarantee supply.